Alternative HIV Therapies

We concur with the letter appearing in The Scientist, Feb. 17, 1997, by H. Hugh Fudenberg [page 13], which states that potentially effective alternative HIV therapies exist today and are attracting interest and undergoing active investigation. These alternative therapies have not been given fair consideration in comparison to the exploitation of pharmaceuticals. In the past, the proclamation that AZT would revolutionize the treatment of this life-threatening illness and provide a possible cure

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

We concur with the letter appearing in The Scientist, Feb. 17, 1997, by H. Hugh Fudenberg [page 13], which states that potentially effective alternative HIV therapies exist today and are attracting interest and undergoing active investigation. These alternative therapies have not been given fair consideration in comparison to the exploitation of pharmaceuticals. In the past, the proclamation that AZT would revolutionize the treatment of this life-threatening illness and provide a possible cure has been only partially true. When AZT did not live up to all hopes, other pharmaceuticals were developed and released with equal promise. These have also met with less than expected results, until the new wave of protease inhibitors. The initial data on these protease inhibitors appear promising; however, adverse reactions have limited their universal use. Eventual resistance is an issue that has been considered with marginal acceptance, and because of this its full impact has yet to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Linda Shecterle

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide